Effect of Repeated Doses of Acetaminophen on a Continuous Glucose Monitoring System with Permselective Membrane
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Continuous glucose monitoring systems use an electrochemical methodology for measuring glucose in interstitial fluid (ISF). Dexcom G6 uses a measurement voltage where other common compounds may get oxidized. The diffusion membrane can block some of the interfering compounds; however, not all compounds can be blocked due to their molecular mass. Dexcom G4 and G5 systems showed significant interference from acetaminophen.1-3 Dexcom introduced a permselective membrane in G6 that blocks the diffusion of acetaminophen to the electrode surface thereby minimizing its effect.4 In the clinical study performed by Dexcom, the study participants were asked not to take any acetaminophen from the day before sensor insertion until the in-clinic session, where study subjects were asked to take 1 g of acetaminophen and were followed for 8 hours. The study’s objective was met in that the observed mean interference effect was 3.1 ± 4.8 mg/dL, which was statistically significantly lower than the performance goal of 10 mg/dL. The authors concluded that this interference effect would have a negligible effect on bolus insulin administered. The authors argued that because the temporal profile of interference with G4 sensors follows that of ISF and plasma acetaminophen concentrations,2 studies of higher or repeated doses were unnecessary. Since the interference from acetaminophen is reduced by using a permselective membrane, its effectiveness should be demonstrated by challenging the membrane with re…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hydroxyurea, used for myeloproliferative disorders and hematologic conditions, is one of the most recently identified interfering substances that cause a temporary increase in sensor glucose values discrepant from actual glucose values (129-134).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [134]
Citations
Cites
Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
Maahs, D. M., DeSalvo, D., Pyle, L., Ly, T., Messer, L., Clinton, P., Westfall, E., Wadwa, R. P., & Buckingham, B. (2015) · Diabetes Care · doi:10.2337/dc15-1096 · Cited by 102
Basu, A., Veettil, S., Dyer, R. B., Peyser, T. A., & Basu, R. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0410 · Cited by 94 · cited 2×
“518 Journal of Diabetes Science and Technology 15(2)”
Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study
Basu, A., Slama, M. Q., Nicholson, W. T., Langman, L., Peyser, T., Carter, R., & Basu, R. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817697329 · Cited by 77
Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System
Calhoun, P. M., Johnson, T. K., Hughes, J., Price, D. A., & Balo, A. K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818755797 · Cited by 62
Cited by
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., Buckingham, B. A., Carroll, J., Ceriello, A., Chow, E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00319-9 · Cited by 831
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology
Galindo, R. J., & Aleppo, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108502 · Cited by 158
Metadata
- Authors
- Denham, D.
- Affiliations
- Clinical Trials of Texas (US)
- Corresponding author
- Denham, Douglas
- ORCID
- Denham, Douglas
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2020-08-29
- Volume
- 15
- Issue
- 2
- Pages
- 517-518
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC8256057
- OpenAlex
- W3082759272
- Cited by
- 28
- References
- 4
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 3 · 2020: 1
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- abbott diabetes care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Physical Sciences › Chemistry › Analytical Chemistry › Electrochemical sensors and biosensors
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Chemistry and Sensors
- Keywords
- paracetamol, continuous glucose monitoring, permselective membranes, repeated dosing, drug interference, glucose sensor
- MeSH terms
- Acetaminophen, Blood Glucose, Diabetes Mellitus, Type 1, Humans, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Repeated Doses of Acetaminophen on a Continuous Glucose Monitoring System with Permselective Membrane. https://app.cochat.ai/papers/10.1177/1932296820948544
- The paper
- Denham, D. (2021). Effect of Repeated Doses of Acetaminophen on a Continuous Glucose Monitoring System with Permselective Membrane. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820948544
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.